Whole blood transfusion for trauma is standard practice in poor countries and a hot trend in rich ones

University of Cambridge

In high-income trauma centers, donated blood is separated into its components: packed red blood cells, plasma, platelets. Each component is stored differently, administered differently, and tracked separately. This component therapy has been the standard of care for decades.

In lower-resource hospitals across much of the world, blood goes in as it comes out: whole. No separation, no fractionation, no cold chain for platelets. It is simpler to store, faster to deliver, and it has been the routine approach to trauma resuscitation for as long as these hospitals have been operating.

Now the high-income world is rediscovering whole blood. Military medicine brought it back first. Civilian trauma centers have followed. And a new study published in The Lancet eClinicalMedicine suggests that the countries with the most experience using whole blood in emergencies are the ones least likely to be consulted about it.

187 hospitals, 51 countries, one question

The GOAL-Trauma study, led by the University of Cambridge, analyzed data from 1,768 patients treated at 187 hospitals across 51 countries. It is the first multicentre international study to report on blood transfusion strategies for patients undergoing emergency abdominal surgery after trauma.

Uncontrolled bleeding is the leading cause of death after abdominal trauma, making transfusion strategy a direct determinant of survival. Yet the study found marked variation in how blood is delivered, and the variation tracks closely with resources.

Hospitals in higher-resource settings were significantly more likely to use component therapy. Whole blood was more than twice as common in lower-resource settings. Neither approach has been rigorously proven superior to the other in this context, which is precisely why the variation matters.

Experience flowing in the wrong direction

Dr. Joachim Amoako of the University of Ghana notes that whole blood has been a routine part of trauma resuscitation in settings like his for a long time. The logistics of blood separation require equipment, cold storage, and supply chain management that many hospitals do not have. Whole blood is not a compromise in these settings. It is a system adapted to local constraints, with decades of practical experience behind it.

As high-income trauma systems begin exploring whole blood programs, that experience base becomes relevant. Organizing volunteer blood donation, maintaining quality without component separation, and delivering whole blood quickly in emergency contexts are all operational challenges that lower-resource hospitals have been solving for years.

The researchers suggest that knowledge sharing should flow in both directions, a departure from the typical model in global health, where clinical practices are developed in wealthy countries and adapted for poorer ones.

A cheap drug that almost nobody uses

The study's other major finding concerns tranexamic acid (TXA), an inexpensive medication that reduces death from traumatic bleeding when given early. The World Health Organization lists it as an essential medicine. The evidence supporting its use is strong. It is widely available even in lower-resource settings, and it is already routinely used for obstetric hemorrhage.

Despite all of that, TXA was administered in fewer than 30% of cases globally.

Professor Timothy Hardcastle of the University of KwaZulu-Natal calls the finding concerning. The drug costs pennies per dose. It does not require specialized training to administer. The clinical evidence is not ambiguous. Yet more than two-thirds of trauma laparotomy patients in this study did not receive it.

The gap between evidence and practice in TXA use is not unique to trauma. It reflects a broader pattern in global health where proven, affordable interventions fail to reach the patients who need them, not because of cost or availability but because of habits, guidelines that have not been updated, and systems that do not prompt clinicians to act.

What the study sets up

The researchers position this work as a foundation rather than a conclusion. Understanding the global variation in transfusion practices is a prerequisite for designing studies that can determine which approaches actually produce the best outcomes. The data also provide a baseline for developing context-appropriate guidelines, ones that account for local resources rather than prescribing a single standard.

The whole blood question, in particular, needs controlled trials. The observational data cannot tell us whether whole blood is better, worse, or equivalent to component therapy for trauma laparotomy. What the data do tell us is that millions of patients worldwide are already receiving whole blood, and the clinicians administering it have practical knowledge worth integrating into the evidence base.